Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listPUROMYCIN AMINONUCLEOSIDE

PUROMYCIN AMINONUCLEOSIDE

Synonym(s):3′-Amino-3′-deoxy-N6,N6-dimethyladenosine

  • CAS NO.:58-60-6
  • Empirical Formula: C12H18N6O3
  • Molecular Weight: 294.31
  • MDL number: MFCD00063462
  • EINECS: 200-388-3
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-19 20:33:22
PUROMYCIN AMINONUCLEOSIDE Structural

What is PUROMYCIN AMINONUCLEOSIDE?

Description

Puromycin aminonucleoside (58-60-6) is the nucleoside moiety of puromycin (Cat.# 10-2100) which does not inhibit protein synthesis or induce apoptosis.1?It acts as a glomerular epithelial cell toxin2 and as such is a useful tool for producing animal models of nephropathy3,4, or puromycin aminonucleoside nephrosis (1-2.5 mg/100g rat body weight)5. Active in vivo.

Chemical properties

White crystal

The Uses of PUROMYCIN AMINONUCLEOSIDE

Puromycin aminonucleoside is a semi-synthetic derivative of puromycin which lacks the methoxyphenylalanyl moiety. Puromycin aminonucleoside is the key intermediate in the synthesis of semi-synthetic analogues of puromycin. It does not inhibit protein synthesis or induce apoptosis, but exhibits antitumour properties. Puromycin aminonucleoside-induced nephrosis is a well-described model of human idiopathic nephrotic syndrome, suppressing integrin expression in cultured glomerular epithelial cells.

The Uses of PUROMYCIN AMINONUCLEOSIDE

Puromycin Aminonucleoside is an aminonucleoside portion of the antibiotic puromycin.

What are the applications of Application

Puromycin Aminonucleoside is a glomerular epithelial cell toxin, and aminonucleoside portion of the antibiotic puromycin.

Definition

ChEBI: Puromycin derivative that lacks the methoxyphenylalanyl group on the amine of the sugar ring.

Safety Profile

An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx,.

References

1) Chow et al. (1995), Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis; Exp. Cell Res., 216 149 2) Krishnamurti et al. (2001), Puromycin aminonucleoside suppresses integrin expression in cultured glomerular epithelial cells; J. Am. Soc. Nephrol., 12 758 3) Egashira et al. (2006), Tryptophan-niacin metabolism in rat with puromycin aminonucleoside-induced nephrosis; Int. J. Vitam. Nutr. Res., 76 28 4) Hagiwara et al. (2006), Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis; Kidney Int., 69 1146 5) Lowenborg et al. (2000), Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats; Nephrol. Dial. Transplant, 15 1547

Properties of PUROMYCIN AMINONUCLEOSIDE

Melting point: 235℃ (Decomposition)
Boiling point: 436.08°C (rough estimate)
Density  1.2131 (rough estimate)
refractive index  1.7000 (estimate)
Flash point: >110°(230°F)
storage temp.  Keep in dark place,Inert atmosphere,2-8°C
solubility  H2O: 50 mg/mL, clear, slightly yellow
form  liquid
pka 13.26±0.70(Predicted)
color  White
Water Solubility  Soluble in water at 50mg/ml. May require heating
BRN  93902
Stability: Stable for 1 year as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 2 months.
EPA Substance Registry System Adenosine, 3'-amino-3'-deoxy-N,N-dimethyl- (58-60-6)

Safety information for PUROMYCIN AMINONUCLEOSIDE

Signal word Warning
Pictogram(s)
ghs
Health Hazard
GHS08
GHS Hazard Statements H373:Specific target organ toxicity, repeated exposure
Precautionary Statement Codes P260:Do not breathe dust/fume/gas/mist/vapours/spray.
P314:Get medical advice/attention if you feel unwell.

Computed Descriptors for PUROMYCIN AMINONUCLEOSIDE

InChIKey RYSMHWILUNYBFW-GRIPGOBMSA-N

Related products of tetrahydrofuran

You may like

  • Puromycin aminonucleoside CAS 58-60-6
    Puromycin aminonucleoside CAS 58-60-6
    58-60-6
    View Details
  • 1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%
    1-Methyl-6-oxo-1,6-dihydropyridazine-3-carbonitrile 98%
    99903-60-3
    View Details
  • 1823368-42-8 98%
    1823368-42-8 98%
    1823368-42-8
    View Details
  • 2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%
    1307449-08-6
    View Details
  • Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%
    25408-95-1
    View Details
  • 2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%
    2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%
    1805639-70-6
    View Details
  • 1784294-80-9 98%
    1784294-80-9 98%
    1784294-80-9
    View Details
  • Lithium Clavulanate
    Lithium Clavulanate
    61177-44-4
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.